NEWS
By JMa000295
•
March 26, 2025
Dr. Jonathan Tian visited ReBlood Group in Tainan to discuss AI-driven health innovations and collaboration on March 21, 2025.
By JMa000295
•
December 4, 2024
ReBlood Actively Expands into Southeast Asian Markets, Deepening International Cooperation to Support Listing on U.S. Capital Markets
By JMa000295
•
November 15, 2024
ReBlood invests millions in Yushan AI for automated labs and smart consulting, enhancing privacy and boosting AI healthcare integration.
By JMa000295
•
March 26, 2025
Dr. Jonathan Tian visited ReBlood Group in Tainan to discuss AI-driven health innovations and collaboration on March 21, 2025.
By JMa000295
•
December 4, 2024
ReBlood Actively Expands into Southeast Asian Markets, Deepening International Cooperation to Support Listing on U.S. Capital Markets
By JMa000295
•
November 15, 2024
ReBlood invests millions in Yushan AI for automated labs and smart consulting, enhancing privacy and boosting AI healthcare integration.
Address:
• 7th Floor, No. 375 Yunong Road, East District, Tainan City (Tainan Headquarters)
• 8th Floor, No. 189, Section 1, Yongfu Road, Central West District, Tainan City (Tainan Branch)
• 4th Floor, No. 14, Lane 345, Yangguang Street, Neihu District, Taipei City (Taipei Branch)
• Floor 19, No. 218, Section 1, Wenxin Road, Nantun District, Taichung City (Taichung Branch)
Business hours: Monday to Friday 8:30 - 17:30
Tel: (+886) 6-208-1474
E-mail: contact@rebloodcorp.com